170853 ⎘
Detection or diagnosis of diseases Psychoses; Psychiatry
Sub-classes:ARTIFICIAL INTELLIGENCE-BASED MENTAL ILLNESS DIAGNOSIS SYSTEM AND METHOD USING EXOSOME SERS SIGNALS
#2DEFECTIVE CALCIUM SIGNALING AS A TOOL IN AUTISM SPECTRUM DISORDERS
#3DEXAMETHASONE FOR TREATING AUTISM
#4DIAGNOSIS AND TREATMENT OF AUTISM SPECTRUM DISORDERS BASED ON AMINE CONTAINING METABOTYPES
#5METHODS AND SYSTEMS FOR IDENTIFYING OR TREATING CENTRAL NERVOUS SYSTEMS DISEASE
#6METHODS FOR DIAGNOSING AN AUTISTIC SPECTRUM DISORDER
#7CLASSIFICATION OF NEUROLOGICAL OR PSYCHIATRIC DISEASE MANIFESTATIONS USING MULTI-DIMENSIONAL CEREBROSPINAL FLUID ANALYSIS
#8DEFECTIVE CALCIUM SIGNALING AS A TOOL IN AUTISM SPECTRUM DISORDERS
#9METHODS OF DETERMINING RISK OF SUICIDE BY IMMUNOLOGICAL ASSESSMENT
#10METHODS OF TREATMENT AND DIAGNOSTIC OF PATHOLOGICAL CONDITIONS ASSOCIATED WITH INTENSE STRESS
#11Biomarkers for Efficacy of Prophylactic Treatments Against Stress-Induced Affective Disorders
#12METHOD FOR COLLECTING EXTRACELLULAR VESICLES DERIVED FROM NERVOUS SYSTEM CELLS
#13COMPOSITIONS FOR RESTORING GENE EXPRESSION IN NEUROPSYCHIATRIC OR NEURODEGENERATIVE DISORDERS
#14Predictive Markers of Psychosis
#15ANTIGENIC NEURON SPECIFIC ENOLASE PEPTIDES FOR DIAGNOSING AND TREATING AUTISM
#16TARGETS AND METHODS OF DIAGNOSING, MONITORING AND TREATING FRONTOTEMPORAL DEMENTIA
#17SCREENING METHOD
#18BIOMARKER FOR DIAGNOSING AT-RISK MENTAL STATE
#19METHODS FOR DIAGNOSING OR TREATING POST-TRAUMATIC STRESS DISORDER, AND COMPOSITIONS THEREFOR
#20DEFECTIVE CALCIUM SIGNALING AS A TOOL IN AUTISM SPECTRUM DISORDERS
#21Methods for diagnosing an autistic spectrum disorder
#22METHODS AND COMPOSITIONS FOR DIAGNOSING, TREATING, AND MONITORING TREATMENT OF SHANK3 DEFICIENCY ASSOCIATED DISORDERS
#23METHOD AND BIOMARKERS FOR IN VITRO DIAGNOSIS OF MENTAL DISORDERS
#24DIAGNOSIS AND TREATMENT OF AUTISM SPECTRUM DISORDERS BASED ON AMINE CONTAINING METABOTYPES
#25Biomarkers for efficacy of prophylactic treatments against stress-induced affective disorders
#26Screening method
#27Neurofibromin/dopamine signaling as a biomarker for cognitive and behavioral problems in children with neurofibromatosis type 1 (NF1 )
#28ASSAY FOR PHAGOCYTIC IMMUNE CELL DEFECTS ASSOCIATED WITH AUTISM
#29Methods for ameliorating memory impairment in a memory disorder caused by neuronal cell death or Abeta aggregation using a peptide
#30DIAGNOSTIC METHOD FOR PEDIATRIC ACUTE-ONSET NEUROPSYCHIATRIC SYNDROME (PANS) AND PEDIATRIC AUTOIMMUNE NEUROPSYCHIATRIC DISORDER ASSOCIATED WITH STREPTOCOCCI INFECTION (PANDAS)
#31Defective calcium signaling as a tool in autism spectrum disorders
#32Biomarkers for diagnosing post traumatic stress disorder
#33BIOMARKERS
#34Screening method
#35Therapeutic and diagnostic methods for autism spectrum disorders and other conditions
#36Genetic markers for suicide risk and related methods
#37INVOLVEMENT OF THE BUFODIENOLIDES IN THE DIAGNOSIS AND TREATMENT OF POST-TRAUMATIC STRESS DISORDER (PTSD)
#38Method for diagnosing psychiatric disorders
#39METHODS FOR DETERMINING THE RISK OF A SYSTEMIC LUPUS ERYTHEMATOSUS (SLE) PATIENT TO DEVELOP NEUROPSYCHIATRIC SYNDROMES
#40Method for decreasing depression-like behavior with connective tissue growth factor (CTGF) inhibitor
#41COMPOSITIONS AND METHODS FOR DIAGNOSIS OF AUTISM SPECTRUM DISORDER
#42Diagnostic method for pediatric acute-onset neuropsychiatric syndrome (PANS) and pediatric autoimmune neuropsychiatric disorder associated with streptococci infection (PANDAS)
#43Indole and indoline derivatives and methods of use thereof
#44Method and system for microbiome-derived diagnostics and therapeutics for mental health associated conditions
#45Method and system for microbiome-derived diagnostics and therapeutics for mental health associated conditions
#46Method and system for microbiome-derived diagnostics and therapeutics for mental health associated conditions
#47Method and system for microbiome-derived diagnostics and therapeutics for mental health associated conditions
#48METHODS OF MONITORING FOR ADHERENCE TO ARIPIPRAZOLE THERAPY
#49Trigeminal neurostimulation based upon pulse counting and chronobiology
#50Quantifying biomarkers for diagnosing and treating schizophrenia, bipolar disorder or major depression
#51Method for detecting GABAA receptor autoantibodies
#52Method and system for microbiome-derived diagnostics and therapeutics for mental health associated conditions
#53Method and kit for dynamic gene expression monitoring
#54NEUROFIBROMIN/DOPAMINE SIGNALING AS A BIOMARKER FOR COGNITIVE AND BEHAVIORAL PROBLEMS IN CHILDREN WITH NEUROFIBROMATOSIS TYPE 1 (NF1)
#55MENTAL ILLNESS MODEL AND MENTAL ILLNESS RISK ASSESSMENT TEST FOR SCHIZOPHRENIC PSYCHOSIS
#56Therapeutic and diagnostic methods for autism spectrum disorders and other conditions
#57Method of producing microglial cells
#58Maternal TH17 cells and psychiatric disorders
#59Use of ghrelin or functional ghrelin receptor agonists to prevent and treat stress-sensitive psychiatric illness
#60Methods of determining response to therapy
#61Methods for increasing DISC1 in a subject with schizophrenia or bipolar disorder by an antagonist inhibiting DISC1 binding to FBXW7
#62Methods of treating fragile X syndrome and related disorders
#63Diagnostic method for pediatric acute-onset neuropsychiatric syndrome (PANS) and pediatric autoimmune neuropsychiatric disorder associated with streptococci infection (PANDAS)
#64COMPOSITIONS AND METHODS COMPRISING BACTERIA FOR IMPROVING BEHAVIOR IN NEURODEVELOPMENTAL DISORDERS
#65Schizophrenia-associated genetic loci identified in genome wide association studies and methods of use thereof
#66CC2D2A gene mutations associated with Joubert syndrome and diagnostic methods for identifying the same
#67GAMMA-AMINOBUTYRIC ACID A RECEPTOR SUBUNIT BIOMARKERS
#68Biomarkers
#69Methods to Assess Treatment Outcomes in Reward Deficiency Syndrome (RDS) Behaviors Utilizing Expression Profiling
#70NOVEL THERAPEUTIC AND DIAGNOSTIC PRODUCTS AND METHODS
#71Health test for a broad spectrum of health problems
#72Methods of monitoring for adherence to aripiprazole therapy
#73Screening method
#74System and method for quantifying fragile X mental retardiation 1 protein in tissue and blood samples
#75Protofibril-binding antibodies and their use in thereapeutic and diagnostic methods for parkinson's disease, dementia with lewy bodies and other alpha-synucleinopathies
#76INFORMATION ACQUISITION APPARATUS ON CONCENTRATION OF THIOREDOXINS IN SAMPLE, STRESS LEVEL INFORMATION ACQUISITION APPARATUS AND STRESS LEVEL JUDGING METHOD
#77METHODS FOR THE DIAGNOSIS, RISK ASSESSMENT, AND MONITORING OF AUTISM SPECTRUM DISORDERS
#78Protofibril-binding antibodies and their use in therapeutic and diagnostic methods for Parkinson's disease, dementia with lewy bodies and other α-synucleinopathies
#79CC2D2A gene mutations associated with joubert syndrome and diagnostic methods for identifying the same
#80Diagnosis of depression
#81COMPOSITIONS AND METHODS FOR EVALUATING COGNITIVE DEFECTS
#82Methods for treating nicotinic acetylcholine receptor associated diseases
#83Methods to assess treatment outcomes in Reward Deficiency Syndrome (RDS) behaviors utilizing expression profiling
#84BIOMARKERS FOR THE DIAGNOSIS AND/OR PREDICTION OF SUSCEPTIBILITY TO MENTAL AND NEURODEGENERATIVE DISORDERS
#85USE OF BASIC PROLIN-RICH LACRIMAL GENE PRODUCTS, SUCH AS OPIORPHIN, AS A BIOMARKER
#86Health test for a broad spectrum of health problems
#87COMPOSITIONS AND METHODS FOR DIAGNOSING AND TREATING MENTAL DISORDERS
#88METHODS AND BIOMARKERS FOR DIAGNOSING AND MONITORING PSYCHOTIC DISORDERS
#89Methods for the diagnosis, risk assessment, and monitoring of autism spectrum disorders
#90Diagnosis and treatment of autism using CD38
#91Methods of treating autism spectrum disorders and compositions for same
#92COMPOSITIONS AND METHODS FOR DIAGNOSING AND TREATING NEUROPSYCHIATRIC DISORDERS
#93METHODS FOR TREATMENT AND DIAGNOSIS OF PSYCHIATRIC DISORDERS
#94CC2D2A gene mutations associated with Joubert syndrome and diagnostic methods for identifying the same
#95Indole and indoline derivatives and methods of use thereof
#96MEASUREMENT OF ARYLESTERASE ENZYMATIC ACTIVITY AND ASSESSMENT OF GENETIC POLYMORPHISMS LOCATED IN THE PON1 GENE AS A DIAGNOSTIC TOOL IN AUTISM-SPECTRUM DISORDERS
#97Method and kit for dynamic gene expression monitoring
#98Novel therapeutic and diagnostic products and methods
#99Treatment of autism spectrum disorders with agents that activate the Locus Coeruleus-Noradrenergic system
#100Methods and biomarkers for diagnosing and monitoring psychotic disorders
#101METHODS, COMPOSITIONS AND USES THEREOF
#102Indole and indoline derivatives and methods of use thereof
#103Lipidomics approaches for central nervous system disorders
#104Genetic profiles associated with the 957C>T polymorphism in the DRD2 gene
#105Methods to Monitor, Diagnose and Identify Biomarkers for Psychotic Disorders
#106Method for identifying antipsychotic drug candidates
#107VDCC Gamma-8 Ion Channel
#108GPR 26 G-Protein Coupled Receptor
#109Method for diagnosing a pervasive developmental disorder
#110System and method for using platelet biomarkers for diagnosis and treatment of neuro-psychiatric conditions
#111Diagnostic method for brain damage-related disorders
#112Trace amine receptor 1 of the african green monkey
#113Compositions and Methods For Determining and Predicting Treatment Responses For Depression and Anxiety
#114Methods for diagnosing bipolar disorder
#115Methods for diagnosing major depression or schizophrenia
#116Methods for Diagnosing Schizophrenia
#117Proteins related to schizophrenia and uses thereof
#118Treatment and screening methods for promoting neurogenesis
#119Information acquisition apparatus on concentration of thioredoxins in sample, stress level information acquisition apparatus and stress level judging method
#120Compositions and methods for diagnosing and treating neuropsychiatric disorders
#121Trace amine receptor 1 of the African green monkey
#122Proteins related to schizophrenia and uses thereof
#123Method for diagnosing or predicting susceptibility to psychiatric disorders
#124Compositions and methods for diagnosing and treating mental disorders
#125Generation and delivery of customized content programs